Literature DB >> 19999384

Bioequivalence, therapeutic equivalence and generic drugs.

R K Verbeeck.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19999384     DOI： 10.1179/acb.2009.063

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN： 1784-3286            Impact factor:   1.264


× No keyword cloud information.
  2 in total

Review 1.  Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

Authors:  Robert J Straka; Denis J Keohane; Larry Z Liu
Journal:  Am J Ther       Date:  2017-05       Impact factor: 2.688

2.  A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways.

Authors:  Kevin Klein; Gerrit Borchard; Vinod P Shah; Beat Flühmann; Scott E McNeil; Jon S B de Vlieger
Journal:  Ann N Y Acad Sci       Date:  2021-07-22       Impact factor: 5.691
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.